Geron in the crisis after the shift in strategy away from stem cells
Posted on: October 3, 2012
by Jeffrey Clark 10 September 2012
Geron has been around for a while… more than 20 years to be exact. The majority of known gardener as the mother of cells of CA North, fighting for the pioneers of the new treatments under the direction of CEO Tom Okarma.
Well, Tom Okarma has disappeared, who resigned in February of last year. And ten months ago new CEO John Scarlett of Geron has decided to completely abandon two decades of research on stem cells to focus on the development of anti-cancer drugs. And now research programs did not get any results. The result can be catastrophic that Geron is now fighting for its existence, as it has for the past two decades with billions of dollars invested in research and testing, but not marketed drugs to show.
FierceBiotech feels strongly about it, which they describe as ‘crisis’ company Geron.
FierceBiotech
Cancel reply
Leave a comment
Name
Latisse Review and Coupons 
Leave a comment